Bhat: From a medication standpoint, there is still much to uncover regarding why treatments vary in effectiveness among ...

Despite recent ASCO and FDA guidance recommending the inclusion of people living with HIV in pivotal cancer trials, nearly 75 ...

Stopping unnecessary cancer screenings can take over a decade after new guidelines are introduced, according to a review ...

Bhat: I am an embedded clinical pharmacist and a part of the IBD medical home at Cleveland Clinic. In caring for patients ...

Bhat: With the rapidly advancing landscape of IBD treatments and the increasing complexities of the health care system, integrating clinical pharmacists into IBD care teams offers substantial benefits ...

The FDA has accepted Aquestive Therapeutics’ new drug application for its Anaphylm sublingual epinephrine film for treating ...

Bhat: I appreciate the growing emphasis on incorporating patient quality-of-life assessments into clinical trials and practice, given the significant impact of this disease. Continuously integrating ...

Anal cancer screening among men who have sex with men with HIV aged 35 years and older appeared cost-effective and could decrease anal cancer incidence and mortality, according to research published ...

Optometrists are well placed to notice signs of mental health issues in their patients and take action, according to a ...

Glaucoma is the second leading cause of blindness in the U.S.A primary screening tool for glaucoma is measurement of IOP. The ...

The FDA has approved Gamifant as the first-ever treatment for macrophage activation syndrome in Still’s disease for adults ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...